Protocol Ledger

NCT05642611 · Phase III · RECRUITING

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Interventional Phase III clinical trial protocol NCT05642611 sponsored by SWOG Cancer Research Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-06-06 Enrollment: 777 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05642611
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)777 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05642611
Protocol FieldVerified Registry Value
NCT IdentifierNCT05642611
Consolidated Lead SponsorSWOG Cancer Research Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment777 participants (ESTIMATED)
Registered Start Date2023-06-06
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI